Shell Company Purchase Agreement between Sinary Bio-Technology Holdings Group, Inc. and Wangyin, CEO of Weikang

Summary

This agreement, dated December 8, 2007, is between Sinary Bio-Technology Holdings Group, Inc. and Wangyin, CEO of Weikang. It outlines that Wangyin will pay $650,000 on behalf of Sinary in connection with a reverse acquisition related to a prior share exchange agreement. The payment will be made in U.S. dollars to an account specified by the investment bank once the agreement is signed by both parties. The agreement becomes effective upon signature by both parties' representatives.

EX-10.6 3 v175643_ex10-6.htm

Exhibit 10.6

SHELL COMPANY PURCHASE AGREEMENT

THIS SHELL COMPANY PURCHASE AGREEMENT (this “Agreement”), is dated as of Dec.8, 2007, by and between Sinary Bio-Technology Holdings Group, Inc. (Party A) and Wangyin,CEO of Weikang (Party B)

WHEREAS, the share exchange agreement between Party A and EXDG.OB as of Dec.7,2007. Party A should pay 650,000 US dollar.

AGREEMENT:

NOW, THEREFORE, in consideration of the mutual covenants and other agreements contained in this Agreement, both parties hereby agree as follows:

1、

The payment of $650,000 will made by Mr.Wangyin,CEO of Heilongjiang Weikang on behalf of Sinary in connection with the reverse acquisition on December 7, 2007.

2、

Part B will remit the fee to the account the investment bank offered when the agreement is in effective.

3、

Payment： All payment is made in US dollar.

4、

The agreement shall become effective as of the day when the Assignor and the Assignee have affixed their signatures on it.

Part A：Signature of Wangweili CEO of Sinary

Part B：Signature of Wangyin CEO of Weikang